Success Metrics

Active Trials
2(50%)

Phase Distribution

Ph not_applicable
3
75%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(3)
Other(1)

Detailed Status

Recruiting2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 31 (25.0%)
N/A3 (75.0%)

Trials by Status

recruiting250%
not_yet_recruiting125%
unknown125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Multi-strain Probiotic Effects on Self-Reported Constipation

NCT07275866
recruitingnot_applicable

Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis

NCT06595719
not_yet_recruitingphase_3

Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants

NCT06810154
unknownnot_applicable

The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome

NCT01637714

Clinical Trials (4)

Showing 4 of 4 trials
NCT07275866Not Applicable

Multi-strain Probiotic Effects on Self-Reported Constipation

Recruiting
NCT06595719Not Applicable

Multi-Strain Probiotics Supplementation With Standard Care in Mild to Moderate Ulcerative Colitis

Recruiting
NCT06810154Phase 3

Multi-strain Probiotics to Prevent Necrotizing Enterocolitis in Very Preterm Infants

Not Yet Recruiting
NCT01637714Not Applicable

The Effects of Multi-strain Probiotics in Adults With Diarrhea Predominant Irritable Bowel Syndrome

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
4